Status: Recruiting
Safety and Performance Study of the Optimum Transcatheter Aortic Valve
The TAVI (Thubrikar Aortic Valve, Inc.) -1 Study: Safety and Performance Study of the Optimum Transcatheter Aortic Valve- First-in-human study to assess feasibility and safety of the Optimum Aortic Valve Implant
Participants needed: 5
Trial details
Age: 70+Biological sex: AllType: InterventionalSponsor: Thubrikar Aortic Valve, Inc.Updated: Sep 21, 2022Locations: 1
Eligibility criteria
Willing and capable to provide informed consent; [+6]
Congenital unicuspid or bicuspid aortic valve; [+25]